152 related articles for article (PubMed ID: 30145467)
1. BF211, a derivative of bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6/JAK2/STAT3 pathway.
Wu XY; Tian F; Su MH; Wu M; Huang Y; Hu LH; Jin L; Zhu XJ
Int Immunopharmacol; 2018 Nov; 64():24-32. PubMed ID: 30145467
[TBL] [Abstract][Full Text] [Related]
2. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
Liu M; Feng LX; Sun P; Liu W; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
PLoS One; 2016; 11(7):e0159789. PubMed ID: 27459387
[TBL] [Abstract][Full Text] [Related]
3. MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
Xiang RF; Wang Y; Zhang N; Xu WB; Cao Y; Tong J; Li JM; Wu YL; Yan H
Cell Death Dis; 2017 May; 8(5):e2776. PubMed ID: 28492559
[TBL] [Abstract][Full Text] [Related]
4. Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.
Zhu S; Wang Z; Li Z; Peng H; Luo Y; Deng M; Li R; Dai C; Xu Y; Liu S; Zhang G
Oncotarget; 2015 Apr; 6(12):10460-72. PubMed ID: 25865044
[TBL] [Abstract][Full Text] [Related]
5. A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.
Zhang Z; Mao H; Du X; Zhu J; Xu Y; Wang S; Xu X; Ji P; Yu Y; Cao B; Han K; Hou T; Xu Z; Kong Y; Jiang G; Tang X; Qiao C; Mao X
Oncotarget; 2016 Feb; 7(8):9296-308. PubMed ID: 26814430
[TBL] [Abstract][Full Text] [Related]
6. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
7. Bufothionine induces autophagy in H22 hepatoma-bearing mice by inhibiting JAK2/STAT3 pathway, a possible anti-cancer mechanism of cinobufacini.
Kong WS; Shen FX; Xie RF; Zhou G; Feng YM; Zhou X
J Ethnopharmacol; 2021 Apr; 270():113848. PubMed ID: 33485977
[TBL] [Abstract][Full Text] [Related]
8. Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly.
Sun P; Feng LX; Zhang DM; Liu M; Liu W; Mi T; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
Acta Pharmacol Sin; 2016 Jul; 37(7):908-18. PubMed ID: 27238210
[TBL] [Abstract][Full Text] [Related]
9. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.
Scuto A; Krejci P; Popplewell L; Wu J; Wang Y; Kujawski M; Kowolik C; Xin H; Chen L; Wang Y; Kretzner L; Yu H; Wilcox WR; Yen Y; Forman S; Jove R
Leukemia; 2011 Mar; 25(3):538-50. PubMed ID: 21164517
[TBL] [Abstract][Full Text] [Related]
10. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells.
Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH
Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343
[TBL] [Abstract][Full Text] [Related]
11. A natural compound derivative P-13 inhibits STAT3 signaling by covalently inhibiting Janus kinase 2.
Huang H; Niu J; Wang F; Hu L; Yu Q
Invest New Drugs; 2019 Jun; 37(3):452-460. PubMed ID: 30073465
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway.
Xu X; Han K; Zhu J; Mao H; Lin X; Zhang Z; Cao B; Zeng Y; Mao X
Oncotarget; 2016 Nov; 7(46):75539-75550. PubMed ID: 27705908
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
Yang L; Zhou F; Zhuang Y; Liu Y; Xu L; Zhao H; Xiang Y; Dai X; Liu Z; Huang X; Wang L; Zhao C
Br J Cancer; 2021 Feb; 124(3):645-657. PubMed ID: 33122847
[TBL] [Abstract][Full Text] [Related]
14. Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway.
Kim HJ; Kim SM; Park KR; Jang HJ; Na YS; Ahn KS; Kim SH; Ahn KS
Cancer Lett; 2011 Feb; 301(1):29-37. PubMed ID: 21122982
[TBL] [Abstract][Full Text] [Related]
15. Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway.
Qiu C; Zhang T; Zhu X; Qiu J; Jiang K; Zhao G; Wu H; Deng G
Reprod Sci; 2019 Jun; 26(6):829-838. PubMed ID: 30526368
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells.
Zhu Z; Li E; Liu Y; Gao Y; Sun H; Ma G; Wang Z; Liu X; Wang Q; Qu X; Liu Y; Yu Y
World J Surg Oncol; 2012 Oct; 10():228. PubMed ID: 23110625
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells.
Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Koh W; Jung JH; Kim SH; Sung-Hoon K
BMC Cancer; 2012 Jan; 12():28. PubMed ID: 22260501
[TBL] [Abstract][Full Text] [Related]
18. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.
Chai XP; Sun GL; Fang YF; Hu LH; Liu X; Zhang XW
Acta Pharmacol Sin; 2018 Mar; 39(3):415-424. PubMed ID: 29119969
[TBL] [Abstract][Full Text] [Related]
20. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
